Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Santoro

Showing results (111-120 of 201) with videos related to

Pageof 21
Sort By:
Thyroid : Official Journal of the American Thyroid Association|May 11, 2010
CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1Liborio Torregrossa, Pinuccia Faviana, Maria Elena Filice, et al.
Cancer Research|November 13, 2003
Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2Francesca Pentimalli, Monica Dentice, Monica Fedele, et al.
The Journal of Clinical Endocrinology and Metabolism|December 31, 2005
Clinical case seminar: in vivo and in vitro characterization of a novel germline RET mutation associated with low-penetrant nonaggressive familial medullary thyroid carcinomaLeonardo D'Aloiso, Francesca Carlomagno, Michele Bisceglia, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2007
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinomaCristiana Lupi, Riccardo Giannini, Clara Ugolini, et al.
Endocrinology|June 28, 2008
Gene expression in RET/PTC3 and E7 transgenic mouse thyroids: RET/PTC3 but not E7 tumors are partial and transient models of human papillary thyroid cancersAgnès Burniat, Ling Jin, Vincent Detours, et al.
JCO Precision Oncology|August 3, 2023
D898_E901 <i>RET</i> Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent MechanismsTommaso Porcelli, Marialuisa Moccia, Maria Angela De Stefano, et al.
The Science of the Total Environment|June 23, 2023
Experimental and in silico evaluations of the possible molecular interaction between airborne particulate matter and SARS-CoV-2Alice Romeo, Roberto Pellegrini, Maurizio Gualtieri, et al.
European Neurology|March 14, 2018
Dysautonomia as Onset Symptom of Myotonic Dystrophy Type 2Salvatore Rossi, Angela Romano, Anna Modoni, et al.
Cellular and Molecular Neurobiology|May 11, 2026
Fecal miRNome and Proteome Profiling Uncovers Stage-Specific Biomarkers of Alzheimer's Disease in 3×Tg-AD MiceRoberta Vitali, Barbara Tanno, Arianna Casciati, et al.
Oncotarget|February 14, 2018
A dual mechanism of activation of the Sonic Hedgehog pathway in anaplastic thyroid cancer: crosstalk with RAS-BRAF-MEK pathway and ligand secretion by tumor stromaAlessia Parascandolo, Mikko O Laukkanen, Nancy De Rosa, et al.
Pageof 21

Showing results (111-120 of 201) with videos related to

Sort By:
Pageof 21
Thyroid : Official Journal of the American Thyroid Association|May 11, 2010
CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1Liborio Torregrossa, Pinuccia Faviana, Maria Elena Filice, et al.
Cancer Research|November 13, 2003
Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2Francesca Pentimalli, Monica Dentice, Monica Fedele, et al.
The Journal of Clinical Endocrinology and Metabolism|December 31, 2005
Clinical case seminar: in vivo and in vitro characterization of a novel germline RET mutation associated with low-penetrant nonaggressive familial medullary thyroid carcinomaLeonardo D'Aloiso, Francesca Carlomagno, Michele Bisceglia, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2007
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinomaCristiana Lupi, Riccardo Giannini, Clara Ugolini, et al.
Endocrinology|June 28, 2008
Gene expression in RET/PTC3 and E7 transgenic mouse thyroids: RET/PTC3 but not E7 tumors are partial and transient models of human papillary thyroid cancersAgnès Burniat, Ling Jin, Vincent Detours, et al.
JCO Precision Oncology|August 3, 2023
D898_E901 <i>RET</i> Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent MechanismsTommaso Porcelli, Marialuisa Moccia, Maria Angela De Stefano, et al.
The Science of the Total Environment|June 23, 2023
Experimental and in silico evaluations of the possible molecular interaction between airborne particulate matter and SARS-CoV-2Alice Romeo, Roberto Pellegrini, Maurizio Gualtieri, et al.
European Neurology|March 14, 2018
Dysautonomia as Onset Symptom of Myotonic Dystrophy Type 2Salvatore Rossi, Angela Romano, Anna Modoni, et al.
Cellular and Molecular Neurobiology|May 11, 2026
Fecal miRNome and Proteome Profiling Uncovers Stage-Specific Biomarkers of Alzheimer's Disease in 3×Tg-AD MiceRoberta Vitali, Barbara Tanno, Arianna Casciati, et al.
Oncotarget|February 14, 2018
A dual mechanism of activation of the Sonic Hedgehog pathway in anaplastic thyroid cancer: crosstalk with RAS-BRAF-MEK pathway and ligand secretion by tumor stromaAlessia Parascandolo, Mikko O Laukkanen, Nancy De Rosa, et al.
Pageof 21